首页
订购/客服:400-666-5481

GDC-0879,B-Raf抑制剂

    
≥96%

GDC-0879

源叶(MedMol)
S81084 一键复制产品信息
905281-76-7
C19H18N4O2
334.37
(E)-5-(1-(2-hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydroinden-1-one oxime;GDC-0879
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S81084-2mg促销
≥96%

¥400.00 ¥360.00

10 - - - -
S81084-5mg促销
≥96%

¥700.00 ¥630.00

10 - - - -
S81084-25mg促销
≥96%

¥2000.00 ¥1800.00

10 - - - -
S81084-100mg促销
≥96%

¥5150.00 ¥4630.00

5 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: GDC-0879 is a potent and selective B-Raf inhibitor with an IC50 of 0.13 nM
靶点: B-Raf:0.13 nM (IC50);Raf
体外研究: GDC-0879 also inhibits pERK with an IC50 of 63 nM[1]. GDC-0879 represents a novel potent and selective B-Raf inhibitor that is being evaluated as a potential antitumor agent. GDC-0879 exhibits potent inhibition of Raf/MEK/ERK signaling pathway in V600E B-Raf mutant cell lines with low cellular pMEK1 inhibition IC50 estimates of 59 and 29 nM in A375 melanoma and Colo205 colorectal carcinoma cells, respectively.
体内研究: The pharmacokinetic parameters of GDC-0879 after oral administration of 15, 25, 50, 100, and 200 mg/kg in MCT in mice are estimated as follows: ka=8.20 h-1, ke=0.59 h-1, and apparent volume of distribution=6.19 L/kg.
参考文献: 1. Hansen JD, et al. Potent and selective pyrazole-based inhibitors of B-Raf kinase. Bioorg Med Chem Lett. 2008 Aug 15;18(16):4692-5.
2. Wong H, et al. Pharmacodynamics of 2-[4-[(1E)-1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridine-4-yl)-1H-pyrazol-1-yl]ethan-1-ol (GDC-0879), a potent and selective B-Raf kinase inhibitor: understanding relationships between systemic concentrations,
溶解性: soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.991 ml 14.953 ml 29.907 ml
5 mM 0.598 ml 2.991 ml 5.981 ml
10 mM 0.299 ml 1.495 ml 2.991 ml
50 mM 0.06 ml 0.299 ml 0.598 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×